Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Diabetic Nephropathies

Back to Details
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Diabetic Nephropathies.
Kamyar Kalantar-Zadeh M.D.
Connection Strength
9.411
Diabetic Nephropathies
  1. Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders. Curr Opin Nephrol Hypertens. 2022 01 01; 31(1):18-25.
    View in: PubMed
    Score: 0.725
  2. Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease. Semin Nephrol. 2021 03; 41(2):96-103.
    View in: PubMed
    Score: 0.684
  3. Emerging paradigms of treating diabetic nephropathy. Lancet Diabetes Endocrinol. 2018 12; 6(12):912-913.
    View in: PubMed
    Score: 0.582
  4. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis. Am J Kidney Dis. 2018 11; 72(5):701-710.
    View in: PubMed
    Score: 0.570
  5. Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy. Am J Nephrol. 2017; 46(6):459-461.
    View in: PubMed
    Score: 0.547
  6. Dietary Approaches in the Management of Diabetic Patients with Kidney Disease. Nutrients. 2017 Jul 31; 9(8).
    View in: PubMed
    Score: 0.533
  7. Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes. Diabetes Care. 2017 08; 40(8):1050-1057.
    View in: PubMed
    Score: 0.528
  8. Haemodialysis-induced hypoglycaemia and glycaemic disarrays. Nat Rev Nephrol. 2015 May; 11(5):302-13.
    View in: PubMed
    Score: 0.454
  9. Updates on the management of diabetes in dialysis patients. Semin Dial. 2014 Mar; 27(2):135-45.
    View in: PubMed
    Score: 0.421
  10. The extinguished BEACON of bardoxolone: not a Monday morning quarterback story. Am J Nephrol. 2013; 37(3):208-11.
    View in: PubMed
    Score: 0.393
  11. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr Diab Rep. 2012 Aug; 12(4):432-9.
    View in: PubMed
    Score: 0.377
  12. Correlates of low hemoglobin A1c in maintenance hemodialysis patients. Int Urol Nephrol. 2013 Aug; 45(4):1079-90.
    View in: PubMed
    Score: 0.373
  13. Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes. 2012 Mar; 61(3):708-15.
    View in: PubMed
    Score: 0.365
  14. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011 May; 6(5):1041-8.
    View in: PubMed
    Score: 0.345
  15. Glycemic control and burnt-out diabetes in ESRD. Semin Dial. 2010 Mar-Apr; 23(2):148-56.
    View in: PubMed
    Score: 0.321
  16. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract. 2009; 113(1):c54-61.
    View in: PubMed
    Score: 0.305
  17. Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr. 2009 Jan; 19(1):33-7.
    View in: PubMed
    Score: 0.294
  18. Glycemic control in diabetic CKD patients: where do we stand? Am J Kidney Dis. 2008 Oct; 52(4):766-77.
    View in: PubMed
    Score: 0.284
  19. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007 May; 30(5):1049-55.
    View in: PubMed
    Score: 0.259
  20. Medical Nutrition Therapy for Diabetic Kidney Disease. J Ren Nutr. 2021 05; 31(3):229-232.
    View in: PubMed
    Score: 0.173
  21. Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis. J Ren Nutr. 2019 03; 29(2):82-90.
    View in: PubMed
    Score: 0.146
  22. Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data. Nephron. 2017; 135(2):147-153.
    View in: PubMed
    Score: 0.126
  23. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct; 37(10):2864-83.
    View in: PubMed
    Score: 0.110
  24. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014 Oct; 64(4):510-33.
    View in: PubMed
    Score: 0.110
  25. Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am J Kidney Dis. 2014 Jan; 63(1):84-94.
    View in: PubMed
    Score: 0.101
  26. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? Clin J Am Soc Nephrol. 2011 Jul; 6(7):1520-2.
    View in: PubMed
    Score: 0.087
  27. Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis. 2010 Aug; 56(2):338-47.
    View in: PubMed
    Score: 0.082
  28. Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis. 2010 May; 55(5):885-96.
    View in: PubMed
    Score: 0.080
  29. Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. J Diabetes Complications. 2018 Dec; 32(12):1113-1117.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.